Furiex Pharmaceuticals, Inc.
Monday produced some big-time biotech news that moved a number of high-profile stocks. In this article I am looking at what moved, why it moved, and what it may mean to investors.
Keryx Biopharmaceuticals’ (NASDAQ: KERX) future is a little less uncertain
It has been a volatile year for Keryx Biopharmaceuticals: The stock had fallen from $5.00 to $1.50 early in 2012 after top-line data for its drug more »
Done with small and medium Housing stocks last time, this article in my series of articles on small and medium companies of my choice deals in smart picks in Pharma / Bio-Pharma Sector !!